Please login or register first to view this content.
Allergic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Most Highly Allergic People Can Be Safely Immunized Against COVID-19
Anaphylaxis Risk Compared for Monoclonal Antibodies Used for Severe Asthma
Oral Transglutaminase 2 Inhibitor Beneficial in Celiac Disease
FDA Approves Rx-to-OTC Switch for Astepro Allergy Nasal Spray
Etrasimod Granted Orphan Drug Status for Eosinophilic Esophagitis
Drug-Induced Immunosuppression Examined in US Adults
SCIT vs SLIT for Allergic Rhinitis: Efficacy Outcomes Compared
Case Report Highlights Potential for Severe Infection Following Epinephrine Auto-Injection
Guidance Updated for Assessing Allergy Risk of COVID-19 Vaccines
Rash Following Medication Change Prompts Evaluation of Excipient Allergy
Ragwitek Approved for Pediatric Patients With Ragweed Pollen Allergy
Graded Administration of Second COVID-19 Vaccine Dose After Hypersensitivity
Self-Administration Option Approved for Xolair Prefilled Syringe
Trial Evaluating Allergic Reactions to Moderna, Pfizer-BioNTech COVID-19 Vaccines Begins
Frequency Low for Dual Allergy to Cefazolin, Natural Penicillins
FDA Expands Use of Bioelectronic Device ClearUp to Include Sinus Congestion
ACAAI Updates Guidance for Allergic Reactions to COVID-19 Vaccines
Rates of Acute Allergic Reactions to COVID-19 Vaccines Extremely Low
